合計 50 件の最近のインサイダー取引記録が記録されています MoonLake Immunotherapeutics (MLTX), 内訳は 19 件の買い および 31 件の売り. インサイダー買い総額は $21.58M インサイダー売り総額は $61.99M.
最近活動のある主要インサイダーには Bvf Partners L P/il, Santos Da Silva Jorge, Bodenstedt Matthias. インサイダー取引記録は、経営陣が株式の評価と将来の見通しをどう見ているかについての洞察を提供します.
インサイダー取引記録 — MLTX
| 日付 |
氏名 |
役職 |
取引種別 |
株数 |
平均価格 |
価値 |
保有株数 |
| 2026-03-31 |
Bvf Partners L P/il |
10 Percent Owner |
情報に基づく売り |
248,530 |
$16.79 |
$4.17M |
1,039,238 |
| 2026-01-07 |
Santos Da Silva Jorge |
Chief Executive Officer |
RSU 付与（制限付株式） |
520,342 |
$11.29 |
$5.87M |
520,342 |
| 2026-01-07 |
Bodenstedt Matthias |
Chief Financial Officer |
RSU 付与（制限付株式） |
354,296 |
- |
- |
1,276,305 |
| 2026-01-07 |
Reich Kristian |
Chief Scientific Officer |
RSU 付与（制限付株式） |
520,342 |
$11.29 |
$5.87M |
520,342 |
| 2025-12-19 |
Santos Da Silva Jorge |
Chief Executive Officer |
株式返還 |
196,316 |
- |
- |
- |
| 2025-12-19 |
Bodenstedt Matthias |
Chief Financial Officer |
転換（売り） |
8,754 |
- |
- |
- |
| 2025-12-19 |
Reich Kristian |
Chief Scientific Officer |
株式返還 |
35,389 |
- |
- |
- |
| 2025-12-09 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
70,000 |
$14.49 |
$1.01M |
2,878,577 |
| 2025-12-09 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
72,908 |
$14.43 |
$1.05M |
- |
| 2025-12-08 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
130,000 |
$15.08 |
$1.96M |
2,948,577 |
| 2025-12-08 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
130,000 |
$15.08 |
$1.96M |
72,908 |
| 2025-10-08 |
Bodenstedt Matthias |
Chief Financial Officer |
情報に基づく買い |
10,870 |
$9.09 |
$98.81K |
627,536 |
| 2025-09-30 |
Chen Bihua |
Other: Former 10% Owner |
情報に基づく売り |
5,827 |
$6.96 |
$40.56K |
1,994,173 |
| 2025-09-29 |
Chen Bihua |
Other: Former 10% Owner |
情報に基づく売り |
2,800,000 |
$6.61 |
$18.51M |
2,000,000 |
| 2025-09-02 |
Reich Kristian |
Chief Scientific Officer |
株式返還 |
48,978 |
- |
- |
35,389 |
| 2025-07-03 |
Moukheibir Catherine |
Director |
情報に基づく売り |
23,500 |
$48.79 |
$1.15M |
- |
| 2025-06-05 |
Bvf Partners L P/il |
10 Percent Owner |
RSU 付与（制限付株式） |
6,682 |
$48.83 |
$326.28K |
6,682 |
| 2025-06-05 |
Moukheibir Catherine |
Director |
RSU 付与（制限付株式） |
6,682 |
$48.83 |
$326.28K |
6,682 |
| 2025-06-05 |
Loy Spike |
Director |
RSU 付与（制限付株式） |
6,682 |
$48.83 |
$326.28K |
6,682 |
| 2025-06-05 |
Xavier Ramnik |
Director |
RSU 付与（制限付株式） |
6,682 |
$48.83 |
$326.28K |
6,682 |
| 2025-06-05 |
Sturge Simon |
Director |
RSU 付与（制限付株式） |
6,682 |
$48.83 |
$326.28K |
6,682 |
| 2025-06-05 |
Phillips Andrew John |
Director |
RSU 付与（制限付株式） |
6,682 |
$48.83 |
$326.28K |
6,682 |
| 2025-02-27 |
Santos Da Silva Jorge |
Chief Executive Officer |
RSU 付与（制限付株式） |
95,763 |
- |
- |
3,078,577 |
| 2025-02-27 |
Bodenstedt Matthias |
Chief Financial Officer |
RSU 付与（制限付株式） |
95,763 |
- |
- |
616,666 |
| 2025-02-27 |
Reich Kristian |
Chief Scientific Officer |
RSU 付与（制限付株式） |
139,273 |
$41.77 |
$5.82M |
139,273 |
| 2025-01-20 |
Reich Kristian |
Chief Scientific Officer |
転換（売り） |
1,456 |
- |
- |
1,052 |
| 2025-01-20 |
Reich Kristian |
Chief Scientific Officer |
転換（売り） |
3,328 |
- |
- |
2,508 |
| 2024-10-04 |
Bvf Partners L P/il |
10 Percent Owner |
情報に基づく売り |
132,549 |
$50.00 |
$6.63M |
1,287,768 |
| 2024-10-04 |
Sturge Simon |
Director |
情報に基づく売り |
171,000 |
$53.72 |
$9.19M |
171,980 |
| 2024-06-06 |
Moukheibir Catherine |
Director |
RSU 付与（制限付株式） |
7,688 |
$42.44 |
$326.28K |
7,688 |
| 2024-06-06 |
Loy Spike |
Director |
RSU 付与（制限付株式） |
7,688 |
$42.44 |
$326.28K |
7,688 |
| 2024-06-06 |
Xavier Ramnik |
Director |
RSU 付与（制限付株式） |
7,688 |
$42.44 |
$326.28K |
7,688 |
| 2024-06-06 |
Sturge Simon |
Director |
RSU 付与（制限付株式） |
7,688 |
$42.44 |
$326.28K |
7,688 |
| 2024-06-06 |
Phillips Andrew John |
Director |
RSU 付与（制限付株式） |
7,688 |
$42.44 |
$326.28K |
7,688 |
| 2024-06-06 |
Bvf Partners L P/il |
10 Percent Owner |
RSU 付与（制限付株式） |
7,688 |
$42.44 |
$326.28K |
7,688 |
| 2024-02-29 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
4,740 |
$55.89 |
$264.92K |
2,982,814 |
| 2024-02-28 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
56,065 |
$55.00 |
$3.08M |
2,987,554 |
| 2024-02-28 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
28,090 |
$55.00 |
$1.54M |
41,981 |
| 2024-02-27 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
62,810 |
$55.00 |
$3.45M |
3,043,619 |
| 2024-02-27 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
29,431 |
$55.00 |
$1.62M |
70,071 |
| 2024-02-21 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
569 |
$55.30 |
$31.47K |
99,502 |
| 2024-02-21 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
1,125 |
$55.27 |
$62.18K |
3,106,429 |
| 2024-02-20 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
20,000 |
$57.44 |
$1.15M |
3,107,554 |
| 2024-02-20 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
10,000 |
$57.43 |
$574.3K |
100,071 |
| 2024-02-16 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
10,000 |
$60.15 |
$601.5K |
110,071 |
| 2024-02-16 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
20,000 |
$60.15 |
$1.2M |
3,127,554 |
| 2024-02-15 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
10,000 |
$60.16 |
$601.6K |
120,071 |
| 2024-02-15 |
Santos Da Silva Jorge |
Chief Executive Officer |
情報に基づく売り |
20,000 |
$60.18 |
$1.2M |
3,147,554 |
| 2024-02-14 |
Reich Kristian |
Chief Scientific Officer |
情報に基づく売り |
10,000 |
$62.43 |
$624.3K |
130,071 |
| 2023-12-20 |
Bodenstedt Matthias |
Chief Financial Officer |
情報に基づく売り |
5,264 |
$58.34 |
$307.1K |
520,903 |
■ 情報付き — 公開市場取引（最も重要）
■ 情報なし（買い） — 報酬・オプション行使・転換
■ 情報なし（売り） — 源泉徴収・付与売却
■ 中立 — 贈与・信託・失効
